Stay updated on Teriflunomide in Pediatric MS Clinical Trial
Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.0%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.8%
- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check53 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and participant eligibility criteria for a clinical trial on teriflunomide in pediatric multiple sclerosis, while adding a new registry identifier and a revision number.SummaryDifference13%
- Check67 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 6, 2025. However, there are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check74 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of February 6, 2025, and version 2.14.2.SummaryDifference0.1%
Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.